Better Therapeutics, Inc. (BTTX)

NASDAQ: BTTX · IEX Real-Time Price · USD
3.64
-0.15 (-3.96%)
At close: Jan 24, 2022 4:00 PM
3.45
-0.19 (-5.22%)
After-hours:Jan 24, 2022 7:58 PM EST

Company Description

Better Therapeutics, Inc. develops prescription digital therapeutics. It is developing Nutritional Cognitive Behavioral Therapy (Nutritional CBT), a behavioral therapy for patients with type 2 diabetes and other cardiometabolic diseases.

Its development pipeline products include BT?001 for type2 diabetes; BT?002 for Type 2 diabetes with hypertension; BT?003 for hypertension; and BT?004 for hyperlipidemia.

The company was incorporated in 2015 and is based in San Francisco, California.

Better Therapeutics, Inc.
CountryUnited States
Founded2015
IndustryBiotechnology
SectorHealth Care
Employees40

Contact Details

Address:
548 Market Street
San Francisco, CA 94104
United States
Phone415 887 2311

Stock Details

Ticker SymbolBTTX
ExchangeNASDAQ
Fiscal YearJanuary - December
Reporting CurrencyUS Dollars
CIK Code1832415

Key Executives

NamePosition
David P. Perry M.B.A.Co-Founder and Executive Chairman
Kevin J. AppelbaumCo-Founder, Chief Executive Officer and Director
Dr. Mark A. Berman M.D.Chief Medical Officer
Kristin WynholdsChief Product Officer
Mark HeinenHead of Finance and Interim Chief Financial Officer
Thiago Licias De OliveiraChief People Officer
Justin ZamirowskiChief Commercial Officer
Andres CamachoHead of Engineering
Dr. Deepti Sodhi Jaggi Pharm.D.Chief Strategy Officer

Latest SEC Filings

DateTypeTitle
Jan 18, 2022SC 13G/AStatement of acquisition of beneficial ownership by individuals
Jan 14, 2022424B3Prospectus [Rule 424(b)(3)]
Jan 14, 20228-K/ACurrent report
Jan 11, 2022S-8Securities to be offered to employees in employee benefit plans
Dec 23, 20214Statement of changes in beneficial ownership of securities
Dec 22, 20214Statement of changes in beneficial ownership of securities
Dec 17, 20214Statement of changes in beneficial ownership of securities
Dec 16, 20214Statement of changes in beneficial ownership of securities
Dec 15, 20214Statement of changes in beneficial ownership of securities
Dec 15, 20214Statement of changes in beneficial ownership of securities
View All SEC Filings